Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD9829 / AstraZeneca
阿斯利康：靶向CD123 ADC产品国内申报临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
阿斯利康 B7-H4 ADC 国内临床即将启动！中国研发提速中_药物_Enhertu_研究
阿斯利康靶向CD123的ADC AZD9829在中国获批临床，治疗血液肿瘤
Discovery of AZD9833, a potent and orally bioavailable selective ...
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising ...
阿斯利康 9 款 1 类新药在中国获批临床，多款国内进度位于第一梯队
AZD-9833 is an Orally Active Estrogen Receptor (ER) Antagonist ...
In Vivo Anticancer Activity of AZD3965: A Systematic Review
Lixarkitug (AZD9829 antibody) | IL-3Ra/CD123 抗体 | MCE
Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the ...
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective ...
Peptide linker conjugation of AZD7762. (A) Structure of DNA damage ...
Discovery and pharmacological characterization of AZD3229, a potent KIT ...
Azacitidine pre-treatment enhances anti-CD123 CAR T cell-mediated AML ...
Azacitidine treatment leads to enhanced CD123 expression on AML ...
AACR2023| ADC药物及可用临床前动物模型 - 知乎
阿斯利康自研ADC崛起_腾讯新闻
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in ...
阿斯利康靶向CD123的ADC AZD9829在中国申报临床，治疗血液肿瘤
AD9869 Datasheet and Product Info | Analog Devices
In vitro anti-inflammatory effects of AZD8999, a novel bifunctional ...
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics ...
Pivekimab sunirine (IMGN 632) is a CD123-targeting ADC for ...
Compilation of 13 FDA-Approved ADC (Antibody-Drug Conjugate) Medications
Full article: Azacitidine and decitabine have different mechanisms of ...
密西根大学张阳实验室郑伟博士在CASP15蛋白质结构预测大赛中斩获多项冠军_casp15冠军-CSDN博客
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia ...
GitHub - marunemitsu/QTFluent: QT Fluent: A Windows11 and Office style ...
有望成为首款！阿尔茨海默病口服TAU蛋白聚集抑制剂HMTM 3期临床试验结果积极
阿斯利康「CD19/CD3双抗」在华获批临床 - 知乎
Molecular characterization and cytotoxic effects of AZD5363, AZD8542 ...
(PDF) Payload diversification: a key step in the development of ...
Dual Src-Abl kinase inhibitors AZD0530 and dasatinib inhibit DV2 ...
AZD8529 ≥98% (HPLC) | Sigma-Aldrich
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain ...
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus ...
AZD9291 binding mode and structure. A, Structural model showing the ...
信达生物口头报告抗IGF-1R抗体IBI311两项临床数据，针对甲状腺眼病
Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus ...
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive ...
AZD8055 inhibits protein translation in AML cells. (a) 7mGTP affinity ...
혈액암 개발 속도 붙이는 AZ…일주일 새 3건 임상 1/2상 IND 승인
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC ...
Synergistic interaction between AZD1208 and AZD2014 in AML cells. A ...
Pharmaceutics | Free Full-Text | Effects of Lactate Transport ...
ADC新药“大闹”AACR医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody ...
AZD8055 | CAS 1009298-09-2 | AbMole BioScience | AZD8055 Price
Discovery of novel hypoxia-activated, nitroimidazole constructed multi ...
泰德制药AT2R拮抗剂TRD205获批临床，针对神经病理性疼痛
c-Myc inhibition synergizes with AZD5991 in inducing apoptosis in AML ...
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and ...
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like ...
(a and b) imprint cytology and (c) histopathology of Serous ...
Combination treatment of cisplatin and AZD−1775 synergistically reduces ...
Signaling and cell cycle effects of AZD8055 treatment with AZD6244. A ...
Antibody–Drug Conjugates: The Last Decade
Antibody-drug Conjugate Information | ADCdb
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
Chinese Medical Journal
Figure 1. | Synergisitic and Antagonistic AML Cell Type-specific ...
Anti Adalimumab (Drug/Target Complex) Antibody, clone AbD20349_hIgG1 ...
AZD0233
slide40
Pharmacological inhibition of ATM using AZD0156 in combination with ...
Multiomics of azacitidine-treated AML cells reveals variable and ...
Preclinical pharmacology of AZD3965 a selective inhibitor of MCT1 ...
The initial metabolic sites of AZD7325 (marked in red) and subsequent ...
Development of Highly Optimized Antibody–Drug Conjugates against CD33 ...
antibody-drug conjugates product brochure | PDF
P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN ...
AZD1222 vaccination induced the enrichment of pro-inflammatory ...
September 2012 – RSC Medicinal Chemistry Blog
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression ...
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
CD123 is an excellent target in primary AML in vivo. (A) Primary AML ...
Frontiers | Reversal of Cancer Multidrug Resistance (MDR) Mediated by ...
Dual Kinase Targeting in Leukemia
Transcriptomic analysis of non-leukemic cell subsets in azacytidine ...
AZD7762 | 购买Chk 抑制剂 - Selleck
Multiomics of Azacitidine-Treated AML Cells Reveals Variable And - DocsLib
AZD1222 elicits neutralizing and non-neutralizing antibodies targeting ...
全球首发！勃林格殷格翰IL-36R单抗佩索利单抗皮下注射制剂在华获批上市
PIM kinase inhibitor, AZD1208, inhibits protein translation and induces ...
Full article: CD123 AML targeting by chimeric antigen receptors
AZD8529 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Impact of Drug Conjugation and Loading on Target Antigen Binding and ...
Unlocking the potential of antibody–drug conjugates for cancer therapy ...
Enhanced antitumor effects of the combination of AZD1208 and an Akt ...
Figure S2. Primary AML cells from 6 patients were treated with AZD1208 ...
-2.jpg)
